Riskpilot← Back to searchSign inGet full accessBioswed Scientific AB
ABActiveOrg 5566640792Grindtorps Skolgränd 44Business and other management consultancy activities · NACE 7020Est. 20040 employees
Revenue 2024
SEK -1
-100% vs 2023
EBITDA margin
5819900.0%
+86% vs 2023
Equity ratio
89.9%
Financial strength
Net profit 2024
SEK 1,2M
+356% vs 2023
| Revenue | SEK -1 | -100% |
| EBITDA | SEK -58K | +86% |
| Net profit | SEK 1,2M | +356% |
| Total assets | SEK 30,9M | -2% |
| Equity | SEK 27,8M | +5% |
| Employees | 0 | — |
Legal name
Bioswed Scientific AB
Org number
5566640792
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
14 juli 2004
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsulttjänster inom företagsutveckling. Bolaget skall bedriva utveckling och kommersialisering av produkter inom tekniksektorn inom rymd, flyg samt medicinsk teknik. Bolaget skall även äga och förvalta värdepapper samt därmed förenlig verksamhet.
Address
Grindtorps Skolgränd 44
Email
david.jern@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | −155 | 135 | −0 |
| Staff expenses | — | — | −3 | −0 | — |
| EBITDA | −128 | −212 | −264 | −423 | −58 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −128 | −212 | −264 | −423 | −58 |
| Net financials | −1 200 | 99 | 4 201 | −55 | 1 280 |
| Profit before tax | −1 221 | 82 | 3 972 | −477 | 1 221 |
| Tax | −0 | −2 | −1 | — | — |
| Net profit | −1 221 | 80 | 3 971 | −477 | 1 221 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 28 437 | 28 335 | 29 169 | 31 655 | 30 898 |
| Equity | 22 991 | 23 070 | 27 041 | 26 564 | 27 785 |
| Long-term debt | 5 069 | 5 069 | 2 069 | 4 569 | 2 969 |
| Short-term debt | 148 | 162 | 59 | 522 | 144 |
| Total debt | 5 217 | 5 231 | 2 128 | 5 091 | 3 113 |
EBITDA margin
-5819900.0%
This company
15.8%
Market median
-36834910% vs market
20202024
Equity ratio
89.9%
This company
38.2%
Market median
+135% vs market
20202024
Return on equity
4.4%
This company
18.4%
Market median
-76% vs market
20202024
Net profit margin
122139900.0%
This company
8.1%
Market median
+1507899900% vs market
20202024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bioswed Scientific AB (this company)
Alumbra Group ABBoard members of Bioswed Scientific AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Magnus Froste | Deputy Board Member | 0 companies |
| David Bengt Olof Jern | Board of Directors | 0 companies |